Skip to content
10-Q

Quarterly Report

BIOSTEM U.S. CORP

0001477932-12-002247

← back to feed
Filed
Jul 12, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Jul 12, 2012 280.49M sh
Operating Cash Flow Q1 2012 · May 31, 2012 −$225.22K
Operating Cash Flow Q1 2012 · May 31, 2011 −$174.16K
Stockholders Equity Q1 2012 · May 31, 2012 −$293.77K
Stockholders Equity Q1 2012 · Feb 29, 2012 −$74.41K
Total Liabilities Q1 2012 · May 31, 2012 $309.45K
Total Liabilities Q1 2012 · Feb 29, 2012 $90.32K
Current Assets Q1 2012 · May 31, 2012 $15.68K
Current Assets Q1 2012 · Feb 29, 2012 $15.9K
Total Assets Q1 2012 · May 31, 2012 $15.68K
Total Assets Q1 2012 · Feb 29, 2012 $15.9K
Sga Expense Q1 2012 · May 31, 2012 $884.36K
Sga Expense Q1 2012 · May 31, 2011 $212.03K
Net Income Q1 2012 · May 31, 2012 −$883.73K
Net Income Q1 2012 · May 31, 2011 −$162.8K
Gross Profit Q1 2012 · May 31, 2012 $624
Gross Profit Q1 2012 · May 31, 2011 $49.24K
Revenue Q1 2012 · May 31, 2012 $624
Revenue Q1 2012 · May 31, 2011 $87.67K
Cost Of Revenue Q1 2012 · May 31, 2011 $38.44K